Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by JPPOUGET
Group name EquipeJPP
Item Type Journal Article
Title [Adhesion of urologists to the recommendations of the French Urological Association Cancer Committee (CCAFU) in the imaging work-up of localized prostate cancer]
Creator Trétarre et al.
Author B. Trétarre
Author S.-G. Trouche-Sabatier
Author A.-S. Foucan
Author N. Abdo
Author G. Poinas
Author D. Azria
Author F. Iborra
Abstract OBJECTIVES: The literature review shows a low adhesion of urologists to the recommendations of learned societies in the imaging work-up of localized prostate cancer (CaP), especially for low and intermediate risks of the D'Amico classification. We analyzed the adhesion of urologists in the Hérault region (France) to the CCAFU 2016/2018, 2018/2020 recommendations. MATERIAL AND METHODS: From the Hérault Onco Urology Registry (RHESOU) database, we identified localized CaP diagnosed between 01/01/2017 and 31/12/2019, and then classified them into 3 distinct risk groups according to the D'Amico classification. We compared the imaging workup performed by each patient to the CCAFU 2016/2018, 2018/2020 recommendations, according to the risk group. RESULTS: Of the 2,049 localized CaPs included in our study, 591 belonged to the low-risk group, 1059 to the intermediate-risk group, and 399 to the high-risk group. In the low-risk group 45.2% of the cases did not follow the CCAFU 2016/2018, 2018/2020 recommendations in the imaging workup, 77.3% in the intermediate-risk group and 80.9% in the high-risk group. For our entire study, 1,408 patients (68.7%) had an imaging workup that did not follow the CCAFU recommendations. CONCLUSION: Our results show a low adhesion of urologists to the CCAFU recommendations in the imaging assessment of localized CaP. The causes of this non-adhesion are multifactorial and difficult to analyze.
Publication Progres En Urologie: Journal De l'Association Francaise D'urologie Et De La Societe Francaise D'urologie
Volume 32
Issue 16
Pages 1446-1454
Date 2022-12
Journal Abbr Prog Urol
Language fre
DOI 10.1016/j.purol.2022.09.021
ISSN 1166-7087
Library Catalog PubMed
Extra Number: 16 PMID: 36344379
Tags clinic, France, Humans, Male, Prostate, Prostatic Neoplasms, Recommandations, Recommendations, Registre, adhésion, Registry, adhesion, review, Urologic Neoplasms, Urologists, Urology
Date Added 2023/11/23 - 12:48:18
Date Modified 2023/11/23 - 12:48:18
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés